EOLS - Evolus, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$14.00
DETAILS
HIGH:
$15.00
LOW:
$13.00
MEDIAN:
$14.00
CONSENSUS:
$14.00
UPSIDE:
144.33%
About Evolus, Inc. (https://www.evolus.com)
Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| David Moatazedi | President, Chief Executive Officer & Director | 1978 | $1,228,948 USD |
| Rui Avelar C.CFP Dip.SportMed | Chief Medical Officer and Head of Research & Development | 1962 | $730,167 USD |
| Tatjana Mitchell | Chief Financial Officer | – | $711,398 USD |
| Jeffrey J. Plumer | Corporate Secretary | – | – |
| Jessica Novak | Senior Vice President of Human Resources | – | – |
| Kurt Knab | Senior Vice President of Sales | – | – |
| Nareg Sagherian | Head of Global Investor Relations & Corporate Communications | – | – |